BioAge Labs Reports Strong Q3 2024 Achievements
BioAge Labs, Inc. ( (BIOA) ) has released its Q3 earnings. Here is a breakdown of the information BioAge Labs, Inc. presented to its investors.
Business Insider10d
BioAge Labs to Present Preclinical Data for APJ Agonist Azelaprag at ObesityWeek 2024
RICHMOND, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. ("BioAge"), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases ...
Yahoo Finance21d
BioAge Labs to Present at Jefferies London Healthcare Conference
RICHMOND, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- BioAge Labs (Nasdaq: BIOA) (“BioAge”), a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic ...
Stockhouse10d
BioAge Labs to Present Preclinical Data for APJ Agonist Azelaprag at ObesityWeek 2024
Nov. 04, 2024 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. ("BioAge"), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting ...
Nasdaq6d
BioAge Labs Reports Third Quarter 2024 Financial Results and Provides Business Updates
RICHMOND, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. ("BioAge", “the Company”), a clinical-stage biotechnology company developing therapeutic ...
Stockhouse6d
BioAge Labs Reports Third Quarter 2024 Financial Results and Provides Business Updates
RICHMOND, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. ("BioAge", “the Company”), a clinical-stage biotechnology company developing therapeutic product candidates ...